|
⚲
|
| Keyboard |
| Tim Kutzkey | |
|---|---|
| Firm | The Column Group Management LP |
| Address | c/o Ngm Bio Holdings, Inc 611 Gateway Blvd, Suite 540 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| The Column Group Management LP | |||||
| The Column Group Opportunity IV LP | 021-567040 | Executive Officer | of 600.0 M |
270.6 M | |
| The Column Group VI LP | 021-567039 | Executive Officer | of 600.0 M |
270.6 M | |
| The Column Group - Neuro II LP | 021-505164 | Executive Officer | 100.0 M of 100.0 M |
98.5 M | |
| The Column Group Opportunity III LP | 021-449435 | Executive Officer | 600.0 M of 600.0 M |
489.2 M | |
| The Column Group SPV I LP | 021-466953 | Executive Officer | 10.5 M of 10.5 M |
10.3 M | |
| The Column Group V LP | 021-449432 | Executive Officer | 600.0 M of 600.0 M |
533.5 M | |
| Ponoi Capital II LP | 021-307049 | Executive Officer | of 100.0 M |
81.6 M | |
| The Column Group IIIA LP | 021-258238 | Executive Officer | 270.5 M of 270.5 M |
139.7 M | |
| The Column Group III LP | 021-258236 | Executive Officer | 239.5 M of 239.5 M |
123.6 M | |
| Neurona Therapeutics Inc | 021-543006 | Director | 101.7 M of 101.7 M |
||
| NILO Therapeutics Inc | 021-520504 | Executive Officer | 9.6 M of 101.0 M |
||
| NGM Bio Holdings Inc | 021-519045 | Director | 142.0 M of 142.0 M |
||
| Site TX Inc | 021-510275 | Director | 6.0 M of 15.0 M |
||
| Neurona Therapeutics Inc | 021-505128 | Director | 120.0 M of 120.0 M |
||
| Carmot Therapeutics Inc | 021-483450 | Director | 150.0 M of 150.0 M |
||
| Carmot Therapeutics Inc | 021-455238 | Director | 160.7 M of 160.7 M |
||
| Neurona Therapeutics Inc | 021-393804 | Director | 72.0 M of 91.6 M |
||
| Surrozen Inc | 021-369446 | Director | 50.0 M of 50.0 M |
||
| Neurona Therapeutics Inc | 021-354176 | Executive Officer | 15.0 M of 50.0 M |
||
| Neurona Therapeutics Inc | 021-306460 | Executive Officer | 10.0 M of 20.0 M |
||
| Carmot Therapeutics Inc | 021-293514 | Director | 10.8 M of 15.4 M |
||
| Kallyope Inc | 021-249469 | Director | 28.1 M of 44.0 M |
||
| Neurona Therapeutics Inc | 021-230717 | Executive Officer | 28.7 M of 30.3 M |
||
| Carmot Therapeutics Inc | 021-181381 | Director | 0.5 M of 1.2 M |
||
| Peloton Therapeutics Inc | 021-162891 | Executive Officer | 11.7 M of 20.0 M |
||
| Cyterix Pharmaceuticals Inc | 021-155865 | Director | 1.5 M of 7.7 M |
||
| Carmot Therapeutics Inc | 021-141033 | Director | 1.5 M of 1.5 M |
||